Customer group: Guest | You do not have the permission to see the prices, please create an account.
Welcome back!

Daratumumab

Darzalex®

   
Filter options: Filter reset
Order number
Concentration
Price
08000086
20 mg/ml
Note: For full product details, please login.
08000235
20 mg/ml
Note: For full product details, please login.
08000063
20 mg/ml
Note: For full product details, please login.
08000235
20 mg/ml
Note: For full product details, please login.
08000235
20 mg/ml
Note: For full product details, please login.

Drug name: Darzalex ®

INN: Daratumumab

API type: Daratumumab is a human monoclonal IgG1κ antibody against CD38 antigen, produced in a mammalian cell line (Chinese Hamster Ovary [CHO]) using recombinant DNA technology.

Pharmacotherapeutic group: Antineoplastic agents, monoclonal antibodies

ATC code: L01XC24

General function:

Short description:

Original license holder:

Marketing authorisation numbers: EU/1/16/1101/001 - 002

Marketing authorisation holder: Janssen-Cilag International NV; Turnhoutseweg 30; B-2340 Beerse; Belgium

Name of the manufacturer of the biological active substance: Biogen Inc.; 5000 Davis Drive; Research Triangle Park; North Carolina; 27709; United States

Name and address of the manufacturer responsible for batch release: anssen Biologics B.V.; Einsteinweg 101 NL-2333 CB Leiden; The Netherlands

Max shelf life: 18 months

Storage conditions: 2°C – 8°C

List of excipients: Glacial acetic acid, Mannitol (E421), Polysorbate 20, Sodium acetate trihydrate, Sodium chloride, Water for injections